Literature DB >> 1315204

Needle sharing behaviour among injection drug users (IDUs) in treatment in Montreal and Toronto, 1988-1989.

R A Coates1, J G Rankin, F Lamothe, R Arshinoff, J Raboud, M E Millson, M L Halliday, J Bruneau, J Soto, J Vincelette.   

Abstract

Injection drug users (IDUs) entering treatment programs in Montreal and Toronto were recruited for a study of drug using behaviour and risk of HIV infection. Only those who had injected within 6 months of entering their treatment program were eligible for participation. 183 subjects were recruited in Montreal and 167 in Toronto between November, 1988 and October, 1989. Each participant completed a standardized interviewer-administered questionnaire which focussed on, among other things, drug history and needle sharing behaviour. Approximately three-quarters of respondents in both cities reported sharing needles and syringes within the 6-month period prior to their entry into treatment. Our analysis, which focussed on variables associated with needle sharing revealed that having a sexual partner who injected, trouble obtaining sterile needles and syringes and cocaine injection were significantly and independently associated with needle sharing in a logistic regression model which also controlled for city of recruitment.

Entities:  

Mesh:

Year:  1992        PMID: 1315204

Source DB:  PubMed          Journal:  Can J Public Health        ISSN: 0008-4263


  3 in total

1.  Injection drug use and preventive measures: a comparison of Canadian and western European jurisdictions over time.

Authors:  B Fischer; J Rehm; T Blitz-Miller
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

Review 2.  Opiate-dependent patients receiving methadone. How physicians should manage therapy.

Authors:  M Kahan; N Sutton
Journal:  Can Fam Physician       Date:  1996-09       Impact factor: 3.275

3.  Sentinel hospital surveillance of HIV infection in Quebec. Quebec Sentinel Hospital HIV-Seroprevalence Study Group.

Authors:  M Alary; J R Joly; R Parent; M Fauvel; M Dionne
Journal:  CMAJ       Date:  1994-10-01       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.